Effectiveness of Scotland's national naloxone programme: response to letter to editor.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

3 citing papers in PubMed.

1. [Prevention of Drug-related Mortality after Release from Prison].Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)) · 2022
   Review
2. The state of harm reduction in prisons in 30 European countries with a focus on people who inject drugs and infectious diseases.Harm reduction journal · 2021
   Article
3. "My first 48 hours out": drug users' perspectives on challenges and strategies upon release from prison.Harm reduction journal · 2021
   Article

Corrections and comments

• Comment on
  Effectiveness of Scotland's National Naloxone Programme for reducing opioid-related deaths: a before (2006-10) versus after (2011-13) comparison.2016
• Comment on
  Effectiveness of Scotland's national naloxone programme.2016

Authors and funding

4 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as